CROWN: Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Completed
CT.gov ID
NCT02639429
Collaborator
(none)
236
1
2
29.7
7.9

Study Details

Study Description

Brief Summary

Obese pregnant women (BMI ≥ 30 kg/m2) are more likely than their normal-weight counterparts to require induction of labor because of increased rates of obstetric complications including pregnancy related hypertensive disorders, diabetes, and prolonged gestations. Several studies have shown that obese women experience increased labor duration and oxytocin needs when compared to normal-weight women. This in turn results in increased rates for unplanned cesarean delivery (CD) as a result of failed induction of labor (IOL), arrest disorders and non-reassuring fetal heart rate tracing, that is dose-dependent with increasing class of obesity. The investigators hypothesize that obese pregnant women and unfavorable cervix (Bishop score ≤ 6), IOL ≥ 24 weeks gestation using the Foley balloon plus vaginal misoprostol will result in reduced cesarean delivery rates when compared to vaginal misoprostol alone.

Condition or Disease Intervention/Treatment Phase
  • Drug: Vaginal Misoprostol
  • Device: Foley Balloon + Vaginal Misoprostol
Phase 4

Detailed Description

Nulliparous pregnant women at ≥ 32 weeks' gestation admitted to labor and delivery for IOL and who meet the inclusion and exclusion criteria will be approached by the research staff. Group 1 will be composed of women allocated to the Foley balloon plus misoprostol. These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team.

Group 2 will be composed of women allocated to vaginal misoprostol-only. These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Similarly, further management will be left at the discretion of the labor team.

In both groups, if IV oxytocin is indicated, it will be withheld until 4 hours after the last dose of misoprostol to prevent uterine hyperstimulation. Other aspects of labor management will be similar for both groups, including continuous electronic fetal monitoring with external Doppler device or fetal scalp electrode. Uterine contraction assessment will be performed with either an external tocodynamometer or an intrauterine pressure catheter.

Study Design

Study Type:
Interventional
Actual Enrollment :
236 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Efficacy of Transcervical Foley Balloon Plus Vaginal Misoprostol Versus Vaginal Misoprostol Alone For Cervical Ripening In Nulliparous Obese Women: A Randomized, Comparative Effectiveness Trial
Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Jun 24, 2018
Actual Study Completion Date :
Jun 24, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Combined approach: Foley Balloon + Vaginal Misoprostol

These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team.

Device: Foley Balloon + Vaginal Misoprostol

Active Comparator: Single approach: Vaginal Misoprostol only

These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team.

Drug: Vaginal Misoprostol
Other Names:
  • Cytotec
  • Outcome Measures

    Primary Outcome Measures

    1. Number of Participants With a Need for Cesarean Delivery [Induction to delivery]

    Secondary Outcome Measures

    1. Indication for Cesarean Delivery [Induction to delivery]

      Categories of Indications for Cesarean Delivery: = Cephalopelvic disproportion = Failed induction/Failure to progress = Cord prolapse = Non-reassuring fetal tracing = Malpresentation = Placental abruption = Other

    2. Induction-to-delivery Interval in Hours [Induction to delivery]

    3. Number of Participants With a Need for Oxytocin Augmentation [Induction to delivery]

    4. Number of Participants Exhibiting Tachysystole Resulting in Fetal Heart Rate Abnormalities [Induction to delivery]

      Uterine tachysystole is a condition of excessively frequent uterine contractions during pregnancy. Tachysystole is indicated ≥ 5 contractions in a 10 minute period averaged over a 30-minute window.

    5. Number of Participants With Clinical Chorioamnionitis [Induction to delivery]

      Clinical chorioamnionitis is indicated by maternal fever ≥ 100.4 Fahrenheit, uterine fundal tenderness, maternal or fetal tachycardia (>100/min and >160/min, respectively), and purulent or foul amniotic fluid.

    6. Number of Participants With a Need for Operative Vaginal Delivery [Induction to delivery]

    7. Composite Maternal Morbidity as Indicated by the Number of Participants With Measures of Maternal Morbidity [Induction to discharge (approximately 5 days)]

      Measures of maternal morbidity assessed: Maternal ICU admission Postpartum endometritis Surgical-site infections prior to discharge Venous thromboembolism Need for transfusion Maternal death

    8. Number of Newborns Admitted to the Neonatal Intensive Care Unit (NICU) [From delivery to neonatal discharge (approximately 2 to 7 days)]

    9. Number of Newborns With Transient Tachypnea (TTN) [From delivery to neonatal discharge (approximately 2 to 7 days)]

    10. Number of Newborns With Respiratory Distress Syndrome (RDS) [From delivery to neonatal discharge (approximately 2 to 7 days)]

    11. Number of Newborns With Meconium Aspiration Syndrome [From delivery to neonatal discharge (approximately 2 to 7 days)]

    12. Number of Newborns With Culture-proven Sepsis [From delivery to neonatal discharge (approximately 2 to 7 days)]

    13. Number of Newborns With Seizures [From delivery to neonatal discharge (approximately 2 to 7 days)]

    14. Composite Neonatal Morbidity as Indicated by the Number of Newborns With Measures of Neonatal Morbidity [From delivery to neonatal discharge (approximately 2 to 7 days)]

      Measures of neonatal morbidity assessed: Apgar score ≤ 7 at 5 mins Umbilical cord potential of hydrogen (pH) < 7.1 Neonatal injury: brachial plexus injury, fracture Perinatal death

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria

    • Nulliparous women aged 18 or above

    • BMI ≥ 30 at the time of labor induction

    • Singleton gestation

    • Cephalic presentation (includes successful external cephalic version)

    • Intact fetal membranes

    • Unfavorable cervix (Bishop score of ≤ 6)

    • Gestational age ≥ 32 weeks

    Exclusion Criteria

    • Patient not candidate for IOL with misoprostol as deemed by the treating physician

    • Multiple gestation

    • Major fetal anomalies

    • Fetal demise

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The University of Texas Health Science Center Houston Texas United States 77030

    Sponsors and Collaborators

    • The University of Texas Health Science Center, Houston

    Investigators

    None specified.

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Mesk A.Jawad Alrais, Clinical Resident, The University of Texas Health Science Center, Houston
    ClinicalTrials.gov Identifier:
    NCT02639429
    Other Study ID Numbers:
    • HSC-MS-15-0895
    First Posted:
    Dec 24, 2015
    Last Update Posted:
    Aug 26, 2019
    Last Verified:
    Aug 1, 2019
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Period Title: Overall Study
    STARTED 113 123
    COMPLETED 113 123
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only Total
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol Total of all reporting groups
    Overall Participants 113 123 236
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    25.3
    (5.8)
    23.4
    (6.1)
    24.3
    (6.0)
    Sex: Female, Male (Count of Participants)
    Female
    113
    100%
    123
    100%
    236
    100%
    Male
    0
    0%
    0
    0%
    0
    0%
    Race/Ethnicity, Customized (Count of Participants)
    African Amercian
    25
    22.1%
    26
    21.1%
    51
    21.6%
    Caucasian
    14
    12.4%
    15
    12.2%
    29
    12.3%
    Hispanic
    68
    60.2%
    74
    60.2%
    142
    60.2%
    Other
    6
    5.3%
    8
    6.5%
    14
    5.9%
    Region of Enrollment (Count of Participants)
    United States
    113
    100%
    123
    100%
    236
    100%
    Gestational Age (weeks) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [weeks]
    38.7
    (5.2)
    38.6
    (5.4)
    38.6
    (5.4)
    Number of participants who are married (Count of Participants)
    Count of Participants [Participants]
    64
    56.6%
    67
    54.5%
    131
    55.5%
    Number of participants who had prenatal care (Count of Participants)
    Count of Participants [Participants]
    110
    97.3%
    121
    98.4%
    231
    97.9%
    Number of participants with government subsidized insurance (Count of Participants)
    Count of Participants [Participants]
    60
    53.1%
    73
    59.3%
    133
    56.4%
    Number of participants with hypertensive disease (Count of Participants)
    Count of Participants [Participants]
    60
    53.1%
    62
    50.4%
    122
    51.7%
    Number of participants with diabetes in pregnancy (Count of Participants)
    Count of Participants [Participants]
    20
    17.7%
    24
    19.5%
    44
    18.6%
    Body Mass index (kg/m^2) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [kg/m^2]
    38.9
    (10.3)
    37.7
    (9.6)
    38.3
    (10.0)
    Bishop score (units on a scale) [Median (Inter-Quartile Range) ]
    Median (Inter-Quartile Range) [units on a scale]
    3
    3
    3

    Outcome Measures

    1. Primary Outcome
    Title Number of Participants With a Need for Cesarean Delivery
    Description
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    51
    45.1%
    53
    43.1%
    2. Secondary Outcome
    Title Indication for Cesarean Delivery
    Description Categories of Indications for Cesarean Delivery: = Cephalopelvic disproportion = Failed induction/Failure to progress = Cord prolapse = Non-reassuring fetal tracing = Malpresentation = Placental abruption = Other
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    Only 51 in the Combined arm and 53 in the single arm delivered by cesarean.
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 51 53
    Arrest disorders
    31
    27.4%
    28
    22.8%
    Nonreassuring fetal heart rate
    13
    11.5%
    18
    14.6%
    Other
    7
    6.2%
    7
    5.7%
    3. Secondary Outcome
    Title Induction-to-delivery Interval in Hours
    Description
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Mean (Standard Deviation) [hours]
    24.8
    (13.8)
    24.5
    (14.0)
    4. Secondary Outcome
    Title Number of Participants With a Need for Oxytocin Augmentation
    Description
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    89
    78.8%
    103
    83.7%
    5. Secondary Outcome
    Title Number of Participants Exhibiting Tachysystole Resulting in Fetal Heart Rate Abnormalities
    Description Uterine tachysystole is a condition of excessively frequent uterine contractions during pregnancy. Tachysystole is indicated ≥ 5 contractions in a 10 minute period averaged over a 30-minute window.
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    10
    8.8%
    20
    16.3%
    6. Secondary Outcome
    Title Number of Participants With Clinical Chorioamnionitis
    Description Clinical chorioamnionitis is indicated by maternal fever ≥ 100.4 Fahrenheit, uterine fundal tenderness, maternal or fetal tachycardia (>100/min and >160/min, respectively), and purulent or foul amniotic fluid.
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    1
    0.9%
    1
    0.8%
    7. Secondary Outcome
    Title Number of Participants With a Need for Operative Vaginal Delivery
    Description
    Time Frame Induction to delivery

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    5
    4.4%
    6
    4.9%
    8. Secondary Outcome
    Title Composite Maternal Morbidity as Indicated by the Number of Participants With Measures of Maternal Morbidity
    Description Measures of maternal morbidity assessed: Maternal ICU admission Postpartum endometritis Surgical-site infections prior to discharge Venous thromboembolism Need for transfusion Maternal death
    Time Frame Induction to discharge (approximately 5 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Maternal ICU Admission
    0
    0%
    3
    2.4%
    Postpartum endometritis
    3
    2.7%
    0
    0%
    Surgical site infection
    5
    4.4%
    1
    0.8%
    9. Secondary Outcome
    Title Number of Newborns Admitted to the Neonatal Intensive Care Unit (NICU)
    Description
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    24
    21.2%
    20
    16.3%
    10. Secondary Outcome
    Title Number of Newborns With Transient Tachypnea (TTN)
    Description
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    5
    4.4%
    5
    4.1%
    11. Secondary Outcome
    Title Number of Newborns With Respiratory Distress Syndrome (RDS)
    Description
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    5
    4.4%
    4
    3.3%
    12. Secondary Outcome
    Title Number of Newborns With Meconium Aspiration Syndrome
    Description
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    Data was not collected for this outcome measure.
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 0 0
    13. Secondary Outcome
    Title Number of Newborns With Culture-proven Sepsis
    Description
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    0
    0%
    1
    0.8%
    14. Secondary Outcome
    Title Number of Newborns With Seizures
    Description
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Count of Participants [Participants]
    0
    0%
    0
    0%
    15. Secondary Outcome
    Title Composite Neonatal Morbidity as Indicated by the Number of Newborns With Measures of Neonatal Morbidity
    Description Measures of neonatal morbidity assessed: Apgar score ≤ 7 at 5 mins Umbilical cord potential of hydrogen (pH) < 7.1 Neonatal injury: brachial plexus injury, fracture Perinatal death
    Time Frame From delivery to neonatal discharge (approximately 2 to 7 days)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    Measure Participants 113 123
    Apgar score < 7 at 5 minutes
    4
    3.5%
    3
    2.4%
    cord pH < 7.1
    5
    4.4%
    5
    4.1%
    any neonatal injury
    3
    2.7%
    3
    2.4%

    Adverse Events

    Time Frame From time of induction to time of discharge (about 5 days for mothers, and about 3-8 days for infants)
    Adverse Event Reporting Description
    Arm/Group Title Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Arm/Group Description These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team. Foley Balloon + Vaginal Misoprostol These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Further management will be left at the discretion of the labor team. Vaginal Misoprostol
    All Cause Mortality
    Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/113 (0%) 0/123 (0%)
    Serious Adverse Events
    Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/113 (0%) 0/123 (0%)
    Other (Not Including Serious) Adverse Events
    Combined Approach: Foley Balloon + Vaginal Misoprostol Single Approach: Vaginal Misoprostol Only
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/113 (0%) 0/123 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Mesk Alrais, MD
    Organization The University of Texas Health Science Center at Houston
    Phone (713) 566-5735
    Email Mesk.A.Alrais@uth.tmc.edu
    Responsible Party:
    Mesk A.Jawad Alrais, Clinical Resident, The University of Texas Health Science Center, Houston
    ClinicalTrials.gov Identifier:
    NCT02639429
    Other Study ID Numbers:
    • HSC-MS-15-0895
    First Posted:
    Dec 24, 2015
    Last Update Posted:
    Aug 26, 2019
    Last Verified:
    Aug 1, 2019